| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | MAML1 NCOA2 NCOA1 NCOA3 NFKBIZ NCOA6 ARID1B TOB1 SSBP3 ARID1A SS18 CREBBP YAP1 EP300 NCOA5 | 6.18e-14 | 562 | 39 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B SSBP3 ARID1A SS18 CREBBP YAP1 EP300 | 3.25e-13 | 303 | 39 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MAML1 NCOA2 NCOA1 NCOA3 NFKBIZ NCOA6 ARID1B TOB1 SSBP3 ARID1A SS18 CREBBP YAP1 EP300 PPP4R2 HGS TNRC6A NCOA5 | 9.70e-13 | 1160 | 39 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | MAML1 NCOA2 NCOA1 NCOA3 NFKBIZ NCOA6 ARID1B TOB1 SSBP3 ARID1A SS18 CREBBP YAP1 EP300 PPP4R2 TAB3 HGS TNRC6A NCOA5 | 1.05e-12 | 1356 | 39 | 19 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 ARID1A CREBBP YAP1 GLI1 EP300 NCOA5 | 9.42e-09 | 739 | 39 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 7.26e-08 | 21 | 39 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.20e-07 | 61 | 39 | 5 | GO:0030374 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.14e-07 | 78 | 39 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.57e-06 | 187 | 39 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.58e-06 | 102 | 39 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.74e-06 | 104 | 39 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.91e-06 | 51 | 39 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 3.40e-06 | 53 | 39 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 3.72e-06 | 2 | 39 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 3.72e-06 | 2 | 39 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.94e-06 | 55 | 39 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.60e-06 | 60 | 39 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 7.67e-06 | 20 | 39 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.11e-05 | 3 | 39 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.19e-05 | 23 | 39 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.38e-05 | 582 | 39 | 8 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.42e-05 | 417 | 39 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 3.95e-05 | 34 | 39 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | transcription factor binding | 8.58e-05 | 753 | 39 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 9.54e-05 | 238 | 39 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.68e-04 | 55 | 39 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.76e-04 | 1459 | 39 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.84e-04 | 15 | 39 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | SMAD binding | 6.30e-04 | 86 | 39 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 6.82e-04 | 206 | 39 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.01e-03 | 229 | 39 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.01e-03 | 229 | 39 | 4 | GO:0003714 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.36e-03 | 875 | 39 | 7 | GO:0019904 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.51e-03 | 891 | 39 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.89e-03 | 33 | 39 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.37e-03 | 37 | 39 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.37e-03 | 37 | 39 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 2.63e-03 | 39 | 39 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 4.99e-03 | 54 | 39 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 5.93e-03 | 59 | 39 | 2 | GO:0031593 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 7.37e-03 | 66 | 39 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 7.37e-03 | 66 | 39 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 7.50e-03 | 1189 | 39 | 7 | GO:0046914 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 9.52e-03 | 1244 | 39 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | p53 binding | 9.92e-03 | 77 | 39 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.06e-02 | 1271 | 39 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.14e-02 | 83 | 39 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.17e-02 | 84 | 39 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.57e-02 | 98 | 39 | 2 | GO:0031491 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.68e-02 | 775 | 39 | 5 | GO:0016746 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MAML1 NCOA2 NCOA1 NCOA3 NFKBIZ NCOA6 CHD7 SSBP3 SS18 CREBBP YAP1 GLI1 TNFSF8 EP300 CREB5 | 8.80e-09 | 1390 | 38 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.95e-06 | 327 | 38 | 7 | GO:0048738 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 2.30e-06 | 51 | 38 | 4 | GO:1902459 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 3.01e-06 | 349 | 38 | 7 | GO:0014706 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA1 NCOA3 NCOA6 SEC24D ZFAND5 CHD7 SSBP3 ARID1A YAP1 EP300 | 3.92e-06 | 906 | 38 | 10 | GO:0043009 |
| GeneOntologyBiologicalProcess | head development | NCOA1 NCOA6 ZFAND5 CHD7 SSBP3 ARID1A CREBBP GLI1 EP300 SAMD4B | 4.45e-06 | 919 | 38 | 10 | GO:0060322 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA1 NCOA3 NCOA6 SEC24D ZFAND5 CHD7 SSBP3 ARID1A YAP1 EP300 | 4.89e-06 | 929 | 38 | 10 | GO:0009792 |
| GeneOntologyBiologicalProcess | face development | 5.40e-06 | 63 | 38 | 4 | GO:0060324 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 6.07e-06 | 741 | 38 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | embryo development | NCOA1 NCOA3 NCOA6 SEC24D ZFAND5 CHD7 SSBP3 ARID1A CREBBP YAP1 GLI1 EP300 | 6.16e-06 | 1437 | 38 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | muscle tissue development | 6.52e-06 | 558 | 38 | 8 | GO:0060537 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.27e-05 | 78 | 38 | 4 | GO:2000036 | |
| GeneOntologyBiologicalProcess | response to hormone | 1.34e-05 | 1042 | 38 | 10 | GO:0009725 | |
| GeneOntologyBiologicalProcess | positive regulation of female receptivity | 1.98e-05 | 4 | 38 | 2 | GO:0045925 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 1.98e-05 | 4 | 38 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.98e-05 | 4 | 38 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.77e-05 | 896 | 38 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 3.03e-05 | 33 | 38 | 3 | GO:0000289 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.31e-05 | 202 | 38 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 4.39e-05 | 727 | 38 | 8 | GO:0032870 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 4.93e-05 | 6 | 38 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | heart development | 5.84e-05 | 757 | 38 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 6.26e-05 | 231 | 38 | 5 | GO:0006352 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 6.40e-05 | 381 | 38 | 6 | GO:0048545 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 6.43e-05 | 561 | 38 | 7 | GO:0048568 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 6.47e-05 | 999 | 38 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 6.49e-05 | 382 | 38 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 7.07e-05 | 237 | 38 | 5 | GO:0019827 | |
| GeneOntologyBiologicalProcess | response to progesterone | 7.76e-05 | 45 | 38 | 3 | GO:0032570 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 7.81e-05 | 242 | 38 | 5 | GO:0098727 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 8.11e-05 | 244 | 38 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 9.35e-05 | 1048 | 38 | 9 | GO:0014070 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 9.40e-05 | 596 | 38 | 7 | GO:0001701 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 9.42e-05 | 48 | 38 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.12e-04 | 136 | 38 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 1.13e-04 | 262 | 38 | 5 | GO:0031669 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 1.18e-04 | 9 | 38 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 1.20e-04 | 52 | 38 | 3 | GO:0042789 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.40e-04 | 144 | 38 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.47e-04 | 146 | 38 | 4 | GO:2000779 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle tissue growth | 1.49e-04 | 56 | 38 | 3 | GO:0055023 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 1.58e-04 | 57 | 38 | 3 | GO:0009299 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.78e-04 | 1141 | 38 | 9 | GO:0045597 | |
| GeneOntologyBiologicalProcess | positive regulation of heart growth | 1.84e-04 | 60 | 38 | 3 | GO:0060421 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.86e-04 | 155 | 38 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | circulatory system development | 2.09e-04 | 1442 | 38 | 10 | GO:0072359 | |
| GeneOntologyBiologicalProcess | female mating behavior | 2.16e-04 | 12 | 38 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 2.19e-04 | 1450 | 38 | 10 | GO:1901701 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 2.20e-04 | 162 | 38 | 4 | GO:0045621 | |
| GeneOntologyBiologicalProcess | labyrinthine layer development | 2.22e-04 | 64 | 38 | 3 | GO:0060711 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 2.22e-04 | 64 | 38 | 3 | GO:0010171 | |
| GeneOntologyBiologicalProcess | respiratory system development | 2.30e-04 | 305 | 38 | 5 | GO:0060541 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 2.33e-04 | 65 | 38 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.33e-04 | 65 | 38 | 3 | GO:0000288 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 2.66e-04 | 68 | 38 | 3 | GO:0141137 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.84e-04 | 713 | 38 | 7 | GO:0048598 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.97e-04 | 14 | 38 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | positive regulation of adipose tissue development | 2.97e-04 | 14 | 38 | 2 | GO:1904179 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell differentiation | 2.97e-04 | 14 | 38 | 2 | GO:2000321 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 3.00e-04 | 1223 | 38 | 9 | GO:0030097 | |
| GeneOntologyBiologicalProcess | positive regulation of organ growth | 3.28e-04 | 73 | 38 | 3 | GO:0046622 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 3.74e-04 | 339 | 38 | 5 | GO:0045927 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 3.79e-04 | 748 | 38 | 7 | GO:0071396 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.90e-04 | 16 | 38 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 3.90e-04 | 16 | 38 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 3.90e-04 | 16 | 38 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 4.01e-04 | 1272 | 38 | 9 | GO:1901698 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 4.12e-04 | 537 | 38 | 6 | GO:0030098 | |
| GeneOntologyBiologicalProcess | adipose tissue development | 4.14e-04 | 79 | 38 | 3 | GO:0060612 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 4.42e-04 | 17 | 38 | 2 | GO:0042921 | |
| GeneOntologyBiologicalProcess | placenta development | 4.62e-04 | 197 | 38 | 4 | GO:0001890 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 4.96e-04 | 18 | 38 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 4.96e-04 | 18 | 38 | 2 | GO:0031958 | |
| GeneOntologyBiologicalProcess | response to nutrient levels | 5.44e-04 | 566 | 38 | 6 | GO:0031667 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 5.50e-04 | 87 | 38 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | regulation of adipose tissue development | 6.79e-04 | 21 | 38 | 2 | GO:1904177 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 7.10e-04 | 95 | 38 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 7.73e-04 | 226 | 38 | 4 | GO:0045580 | |
| GeneOntologyBiologicalProcess | tube development | 8.13e-04 | 1402 | 38 | 9 | GO:0035295 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 8.16e-04 | 23 | 38 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 8.16e-04 | 23 | 38 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 8.16e-04 | 23 | 38 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 8.16e-04 | 23 | 38 | 2 | GO:2000318 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle tissue growth | 8.25e-04 | 100 | 38 | 3 | GO:0055021 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to insulin stimulus | 8.49e-04 | 101 | 38 | 3 | GO:1900076 | |
| GeneOntologyBiologicalProcess | muscle structure development | 8.58e-04 | 858 | 38 | 7 | GO:0061061 | |
| GeneOntologyBiologicalProcess | brain development | 8.64e-04 | 859 | 38 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | response to lipid | 8.68e-04 | 1126 | 38 | 8 | GO:0033993 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 8.80e-04 | 234 | 38 | 4 | GO:0006282 | |
| GeneOntologyBiologicalProcess | notochord development | 8.89e-04 | 24 | 38 | 2 | GO:0030903 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 9.38e-04 | 238 | 38 | 4 | GO:0048639 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 9.45e-04 | 416 | 38 | 5 | GO:0030522 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 9.52e-04 | 239 | 38 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 9.97e-04 | 242 | 38 | 4 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 9.97e-04 | 242 | 38 | 4 | GO:1903708 | |
| GeneOntologyBiologicalProcess | regulation of heart growth | 1.00e-03 | 107 | 38 | 3 | GO:0060420 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 1.01e-03 | 1446 | 38 | 9 | GO:0010628 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 1.03e-03 | 640 | 38 | 6 | GO:1903131 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 1.06e-03 | 246 | 38 | 4 | GO:1902806 | |
| GeneOntologyBiologicalProcess | response to ketone | 1.19e-03 | 254 | 38 | 4 | GO:1901654 | |
| GeneOntologyCellularComponent | npBAF complex | 1.99e-06 | 14 | 38 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | transcription regulator complex | 9.57e-06 | 596 | 38 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.18e-05 | 30 | 38 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | chromatin | NCOA2 NCOA1 NCOA3 ARID1B CHD7 ARID1A SS18 CREBBP EP300 PPP4R2 CREB5 | 4.36e-05 | 1480 | 38 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.27e-04 | 272 | 38 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | bBAF complex | 1.43e-04 | 10 | 38 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | brahma complex | 2.89e-04 | 14 | 38 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 3.80e-04 | 16 | 38 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 6.49e-04 | 1377 | 38 | 9 | GO:0140513 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 7.05e-04 | 96 | 38 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 1.65e-03 | 129 | 38 | 3 | GO:1904949 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 2.07e-08 | 3 | 15 | 3 | HP:0005895 | |
| HumanPheno | Abnormality of dental eruption | 2.20e-06 | 240 | 15 | 7 | HP:0006292 | |
| HumanPheno | Plantar crease between first and second toes | 8.09e-06 | 2 | 15 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 8.09e-06 | 2 | 15 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 8.09e-06 | 2 | 15 | 2 | HP:0001042 | |
| HumanPheno | Square face | 1.13e-05 | 16 | 15 | 3 | HP:0000321 | |
| HumanPheno | Dislocated radial head | 1.41e-05 | 54 | 15 | 4 | HP:0003083 | |
| HumanPheno | Abnormality of the radial head | 1.76e-05 | 57 | 15 | 4 | HP:0003995 | |
| HumanPheno | Laryngeal cartilage malformation | 2.42e-05 | 3 | 15 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 2.42e-05 | 3 | 15 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 2.42e-05 | 3 | 15 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 2.42e-05 | 3 | 15 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 2.42e-05 | 3 | 15 | 2 | HP:0005322 | |
| HumanPheno | Abnormality of the humeroradial joint | 2.46e-05 | 62 | 15 | 4 | HP:0100744 | |
| HumanPheno | Localized hirsutism | 2.66e-05 | 21 | 15 | 3 | HP:0009889 | |
| HumanPheno | Abnormal iliac wing morphology | 3.55e-05 | 68 | 15 | 4 | HP:0011867 | |
| HumanPheno | Trichiasis | 4.84e-05 | 4 | 15 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 4.84e-05 | 4 | 15 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 4.84e-05 | 4 | 15 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 4.84e-05 | 4 | 15 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 4.84e-05 | 4 | 15 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 4.84e-05 | 4 | 15 | 2 | HP:0031207 | |
| HumanPheno | Postnatal growth retardation | 5.41e-05 | 258 | 15 | 6 | HP:0008897 | |
| HumanPheno | Flared iliac wing | 5.79e-05 | 27 | 15 | 3 | HP:0002869 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 8.05e-05 | 5 | 15 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 8.05e-05 | 5 | 15 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 8.05e-05 | 5 | 15 | 2 | HP:0030421 | |
| HumanPheno | Elbow dislocation | 8.18e-05 | 84 | 15 | 4 | HP:0003042 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 9.98e-05 | 174 | 15 | 5 | HP:0009832 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 1.07e-04 | 33 | 15 | 3 | HP:0011587 | |
| HumanPheno | Large foramen magnum | 1.21e-04 | 6 | 15 | 2 | HP:0002700 | |
| HumanPheno | Delayed eruption of teeth | 1.34e-04 | 185 | 15 | 5 | HP:0000684 | |
| HumanPheno | Upper extremity joint dislocation | 1.38e-04 | 96 | 15 | 4 | HP:0030310 | |
| HumanPheno | Sandal gap | 1.38e-04 | 96 | 15 | 4 | HP:0001852 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 1.39e-04 | 36 | 15 | 3 | HP:0009617 | |
| HumanPheno | Deviated nasal septum | 1.69e-04 | 7 | 15 | 2 | HP:0004411 | |
| HumanPheno | Abnormal ilium morphology | 1.88e-04 | 104 | 15 | 4 | HP:0002867 | |
| HumanPheno | Short finger | 1.97e-04 | 325 | 15 | 6 | HP:0009381 | |
| HumanPheno | Abnormal joint physiology | PHEX SEC24D ERBB3 ARID1B CHD7 ARID1A CREBBP GLI1 EP300 TRAK1 MAMLD1 | 2.11e-04 | 1358 | 15 | 11 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | PHEX SEC24D ERBB3 ARID1B CHD7 ARID1A CREBBP GLI1 EP300 TRAK1 MAMLD1 | 2.11e-04 | 1358 | 15 | 11 | HP:0011729 |
| HumanPheno | Spinal cord compression | 2.55e-04 | 44 | 15 | 3 | HP:0002176 | |
| HumanPheno | Pilomatrixoma | 2.88e-04 | 9 | 15 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 2.88e-04 | 9 | 15 | 2 | HP:0002341 | |
| HumanPheno | Prominent fingertip pads | 2.91e-04 | 46 | 15 | 3 | HP:0001212 | |
| HumanPheno | Short stature | PHEX SEC24D ERBB3 ARID1B CHD7 SLC4A4 ARID1A CREBBP GLI1 EP300 TRAK1 | 2.98e-04 | 1407 | 15 | 11 | HP:0004322 |
| HumanPheno | Ventricular septal defect | 3.04e-04 | 510 | 15 | 7 | HP:0001629 | |
| HumanPheno | Delayed skeletal maturation | 3.06e-04 | 352 | 15 | 6 | HP:0002750 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 3.09e-04 | 221 | 15 | 5 | HP:0000932 | |
| HumanPheno | Prominent digit pad | 3.30e-04 | 48 | 15 | 3 | HP:0011298 | |
| HumanPheno | Unsteady gait | 3.30e-04 | 357 | 15 | 6 | HP:0002317 | |
| HumanPheno | Abnormal ventricular septum morphology | 3.48e-04 | 521 | 15 | 7 | HP:0010438 | |
| HumanPheno | Frontal hirsutism | 3.59e-04 | 10 | 15 | 2 | HP:0011335 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 3.78e-04 | 366 | 15 | 6 | HP:0006265 | |
| HumanPheno | Self-mutilation | 3.95e-04 | 51 | 15 | 3 | HP:0000742 | |
| HumanPheno | Long eyelashes | 4.31e-04 | 129 | 15 | 4 | HP:0000527 | |
| HumanPheno | Abnormal subclavian artery morphology | 4.38e-04 | 11 | 15 | 2 | HP:0031251 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 4.43e-04 | 53 | 15 | 3 | HP:0009906 | |
| HumanPheno | Hypospadias | 4.45e-04 | 377 | 15 | 6 | HP:0000047 | |
| HumanPheno | Abnormal skull base morphology | 4.71e-04 | 242 | 15 | 5 | HP:0002693 | |
| HumanPheno | Duodenal ulcer | 5.25e-04 | 12 | 15 | 2 | HP:0002588 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 5.25e-04 | 12 | 15 | 2 | HP:0010746 | |
| HumanPheno | Joint hypermobility | 5.27e-04 | 557 | 15 | 7 | HP:0001382 | |
| HumanPheno | Ptosis | 5.43e-04 | 754 | 15 | 8 | HP:0000508 | |
| HumanPheno | Displacement of the urethral meatus | 5.88e-04 | 397 | 15 | 6 | HP:0100627 | |
| HumanPheno | Neoplasm of the liver | 5.89e-04 | 140 | 15 | 4 | HP:0002896 | |
| HumanPheno | Abnormal male urethral meatus morphology | 6.05e-04 | 399 | 15 | 6 | HP:0032076 | |
| HumanPheno | Facial grimacing | 6.20e-04 | 13 | 15 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 6.20e-04 | 13 | 15 | 2 | HP:0010562 | |
| HumanPheno | Abnormal scrotum morphology | 6.39e-04 | 143 | 15 | 4 | HP:0000045 | |
| HumanPheno | Abnormality of skeletal maturation | 6.55e-04 | 405 | 15 | 6 | HP:0000927 | |
| HumanPheno | Hydronephrosis | 7.04e-04 | 264 | 15 | 5 | HP:0000126 | |
| HumanPheno | Abnormal incisor morphology | 7.04e-04 | 62 | 15 | 3 | HP:0011063 | |
| HumanPheno | Low anterior hairline | 7.09e-04 | 147 | 15 | 4 | HP:0000294 | |
| HumanPheno | Duplication of phalanx of hallux | 7.22e-04 | 14 | 15 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 7.22e-04 | 14 | 15 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 7.22e-04 | 14 | 15 | 2 | HP:0002697 | |
| HumanPheno | Hypoplastic fifth fingernail | 7.22e-04 | 14 | 15 | 2 | HP:0008398 | |
| HumanPheno | Hypoplastic ilia | 7.38e-04 | 63 | 15 | 3 | HP:0000946 | |
| HumanPheno | Duplication of phalanx of toe | 8.31e-04 | 15 | 15 | 2 | HP:0010181 | |
| HumanPheno | Social and occupational deterioration | 8.31e-04 | 15 | 15 | 2 | HP:0007086 | |
| HumanPheno | Abnormality of the dentition | 8.37e-04 | 1030 | 15 | 9 | HP:0000164 | |
| HumanPheno | Hematological neoplasm | 8.38e-04 | 424 | 15 | 6 | HP:0004377 | |
| HumanPheno | Thick eyebrow | 8.45e-04 | 154 | 15 | 4 | HP:0000574 | |
| HumanPheno | Brachydactyly (hand) | 9.04e-04 | 430 | 15 | 6 | HP:0100667 | |
| HumanPheno | Intestinal malrotation | 9.09e-04 | 157 | 15 | 4 | HP:0002566 | |
| HumanPheno | Compulsive behaviors | 9.31e-04 | 158 | 15 | 4 | HP:0000722 | |
| HumanPheno | Abnormality of the elbow | 9.52e-04 | 282 | 15 | 5 | HP:0009811 | |
| HumanPheno | Premature thelarche | 1.07e-03 | 17 | 15 | 2 | HP:0010314 | |
| HumanPheno | Prominent eyelashes | 1.07e-03 | 17 | 15 | 2 | HP:0011231 | |
| HumanPheno | Oral aversion | 1.07e-03 | 17 | 15 | 2 | HP:0012523 | |
| HumanPheno | Dilatation of the renal pelvis | 1.08e-03 | 290 | 15 | 5 | HP:0010946 | |
| HumanPheno | Prenatal growth deficiency | 1.13e-03 | 631 | 15 | 7 | HP:0001515 | |
| HumanPheno | Intrauterine growth retardation | 1.13e-03 | 631 | 15 | 7 | HP:0001511 | |
| HumanPheno | Facial hirsutism | 1.21e-03 | 18 | 15 | 2 | HP:0009937 | |
| HumanPheno | Skin appendage neoplasm | 1.21e-03 | 18 | 15 | 2 | HP:0012842 | |
| HumanPheno | Abnormal dental morphology | 1.24e-03 | 299 | 15 | 5 | HP:0006482 | |
| HumanPheno | Abnormal renal pelvis morphology | 1.26e-03 | 300 | 15 | 5 | HP:0010944 | |
| HumanPheno | Cleft palate | 1.27e-03 | 643 | 15 | 7 | HP:0000175 | |
| HumanPheno | Abnormal hard palate morphology | 1.32e-03 | 647 | 15 | 7 | HP:0100737 | |
| HumanPheno | Spina bifida occulta | 1.33e-03 | 77 | 15 | 3 | HP:0003298 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 3.04e-06 | 268 | 34 | 7 | MP:0011108 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 4.08e-06 | 700 | 34 | 10 | MP:0011098 | |
| MousePheno | embryonic lethality during organogenesis | NCOA6 SEC24D ERBB3 CHD7 SSBP3 ARID1A CREBBP YAP1 EP300 HGS TNRC6A | 4.14e-06 | 876 | 34 | 11 | MP:0006207 |
| MousePheno | abnormal neural tube morphology | 8.24e-06 | 591 | 34 | 9 | MP:0002151 | |
| MousePheno | stereotypic behavior | 1.13e-05 | 214 | 34 | 6 | MP:0001408 | |
| MousePheno | open neural tube | 1.54e-05 | 226 | 34 | 6 | MP:0000929 | |
| MousePheno | abnormal nervous system development | NCOA1 NCOA6 ERBB3 ARID1B CHD7 RBM12 SSBP3 ARID1A SS18 CREBBP EP300 HGS | 2.23e-05 | 1257 | 34 | 12 | MP:0003861 |
| MousePheno | eyelid edema | 3.43e-05 | 4 | 34 | 2 | MP:0006167 | |
| MousePheno | abnormal muscle morphology | MAML1 NCOA3 NCOA6 ERBB3 ZFAND5 CHD7 SLC4A4 ARID1A CREBBP EP300 HGS | 3.78e-05 | 1106 | 34 | 11 | MP:0002108 |
| MousePheno | embryonic lethality, incomplete penetrance | 4.81e-05 | 410 | 34 | 7 | MP:0011102 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 4.81e-05 | 410 | 34 | 7 | MP:0031660 | |
| MousePheno | abnormal prenatal growth/weight/body size | MAML1 NCOA3 NCOA6 CHD7 RBM12 SSBP3 ARID1A SS18 CREBBP YAP1 EP300 HGS | 1.22e-04 | 1493 | 34 | 12 | MP:0004196 |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 1.36e-04 | 208 | 34 | 5 | MP:0011109 | |
| MousePheno | decreased embryo size | 1.43e-04 | 659 | 34 | 8 | MP:0001698 | |
| MousePheno | abnormal embryonic growth/weight/body size | NCOA3 NCOA6 CHD7 RBM12 SSBP3 ARID1A SS18 CREBBP YAP1 EP300 HGS | 1.59e-04 | 1295 | 34 | 11 | MP:0002088 |
| MousePheno | periorbital edema | 1.59e-04 | 8 | 34 | 2 | MP:0001788 | |
| MousePheno | thin myocardium compact layer | 1.86e-04 | 46 | 34 | 3 | MP:0004057 | |
| MousePheno | postnatal growth retardation | 1.89e-04 | 881 | 34 | 9 | MP:0001732 | |
| MousePheno | abnormal synovial joint morphology | 2.23e-04 | 124 | 34 | 4 | MP:0030804 | |
| MousePheno | abnormal embryonic tissue morphology | 2.24e-04 | 1116 | 34 | 10 | MP:0002085 | |
| MousePheno | abnormal postnatal growth | 2.35e-04 | 907 | 34 | 9 | MP:0001731 | |
| MousePheno | abnormal extraembryonic tissue morphology | 2.37e-04 | 908 | 34 | 9 | MP:0002086 | |
| MousePheno | abnormal heart development | 2.44e-04 | 372 | 34 | 6 | MP:0000267 | |
| MousePheno | abnormal periorbital region morphology | 2.55e-04 | 10 | 34 | 2 | MP:0030038 | |
| MousePheno | decreased neuron number | 2.59e-04 | 376 | 34 | 6 | MP:0008948 | |
| MousePheno | abnormal neural tube closure | 2.66e-04 | 378 | 34 | 6 | MP:0003720 | |
| MousePheno | increased stereotypic behavior | 2.83e-04 | 53 | 34 | 3 | MP:0001409 | |
| MousePheno | abnormal embryo turning | 3.26e-04 | 251 | 34 | 5 | MP:0001700 | |
| MousePheno | prenatal lethality, incomplete penetrance | 3.36e-04 | 747 | 34 | 8 | MP:0011101 | |
| MousePheno | kinked neural tube | 3.52e-04 | 57 | 34 | 3 | MP:0003400 | |
| MousePheno | abnormal myocardial trabeculae morphology | 3.94e-04 | 144 | 34 | 4 | MP:0002189 | |
| MousePheno | abnormal myocardium layer morphology | 4.33e-04 | 414 | 34 | 6 | MP:0005329 | |
| MousePheno | short premaxilla | 4.40e-04 | 13 | 34 | 2 | MP:0000091 | |
| MousePheno | abnormal heart layer morphology | 4.79e-04 | 422 | 34 | 6 | MP:0010545 | |
| MousePheno | abnormal gas homeostasis | 5.06e-04 | 600 | 34 | 7 | MP:0003948 | |
| MousePheno | incomplete embryo turning | 5.18e-04 | 65 | 34 | 3 | MP:0001701 | |
| MousePheno | abnormal cardiovascular development | 5.42e-04 | 802 | 34 | 8 | MP:0002925 | |
| MousePheno | lethality throughout fetal growth and development | 5.63e-04 | 435 | 34 | 6 | MP:0006208 | |
| MousePheno | abnormal myocardium compact layer morphology | 5.66e-04 | 67 | 34 | 3 | MP:0004056 | |
| MousePheno | digestive/alimentary phenotype | PHEX NCOA3 NCOA6 SEC24D ERBB3 CHD7 SLC4A4 CREBBP YAP1 EP300 HGS | 5.77e-04 | 1500 | 34 | 11 | MP:0005381 |
| MousePheno | abnormal placenta development | 5.87e-04 | 160 | 34 | 4 | MP:0001712 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | MAML1 NCOA6 ERBB3 ZFAND5 ARID1B SLC4A4 ARID1A CREBBP EP300 CREB5 | 6.32e-04 | 1269 | 34 | 10 | MP:0011111 |
| MousePheno | abnormal fluid regulation | 6.59e-04 | 826 | 34 | 8 | MP:0001784 | |
| MousePheno | ventricle myocardium hypoplasia | 6.71e-04 | 71 | 34 | 3 | MP:0010502 | |
| MousePheno | abnormal neuron number | 7.21e-04 | 456 | 34 | 6 | MP:0008946 | |
| MousePheno | abnormal brain development | 7.31e-04 | 638 | 34 | 7 | MP:0000913 | |
| MousePheno | abnormal pectoral girdle bone morphology | 7.46e-04 | 301 | 34 | 5 | MP:0004508 | |
| MousePheno | absent olfactory bulb | 7.63e-04 | 17 | 34 | 2 | MP:0003451 | |
| MousePheno | abnormal epicardium morphology | 7.63e-04 | 17 | 34 | 2 | MP:0003057 | |
| MousePheno | abnormal blood circulation | 7.66e-04 | 845 | 34 | 8 | MP:0002128 | |
| MousePheno | abnormal hormone level | 8.10e-04 | 1073 | 34 | 9 | MP:0003953 | |
| MousePheno | abnormal gastrulation | 8.35e-04 | 469 | 34 | 6 | MP:0001695 | |
| MousePheno | abnormal frontal bone morphology | 8.50e-04 | 77 | 34 | 3 | MP:0000107 | |
| MousePheno | decreased atrioventricular cushion size | 8.57e-04 | 18 | 34 | 2 | MP:0000301 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 8.57e-04 | 18 | 34 | 2 | MP:0011395 | |
| MousePheno | decreased total body fat amount | 8.92e-04 | 475 | 34 | 6 | MP:0010025 | |
| MousePheno | blepharitis | 9.57e-04 | 19 | 34 | 2 | MP:0005251 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 1.04e-03 | 489 | 34 | 6 | MP:0010630 | |
| MousePheno | thin ventricle myocardium compact layer | 1.06e-03 | 20 | 34 | 2 | MP:0010556 | |
| MousePheno | decreased circulating glucagon level | 1.06e-03 | 20 | 34 | 2 | MP:0002696 | |
| MousePheno | jerky movement | 1.06e-03 | 20 | 34 | 2 | MP:0005424 | |
| MousePheno | abnormal head morphology | 1.10e-03 | 1120 | 34 | 9 | MP:0000432 | |
| MousePheno | thin myocardium | 1.13e-03 | 85 | 34 | 3 | MP:0002652 | |
| MousePheno | abnormal embryo development | 1.15e-03 | 1370 | 34 | 10 | MP:0001672 | |
| MousePheno | abnormal craniofacial morphology | PHEX NCOA3 NFKBIZ NCOA6 ZFAND5 CHD7 SLC4A4 SSBP3 CREBBP EP300 | 1.16e-03 | 1372 | 34 | 10 | MP:0000428 |
| MousePheno | craniofacial phenotype | PHEX NCOA3 NFKBIZ NCOA6 ZFAND5 CHD7 SLC4A4 SSBP3 CREBBP EP300 | 1.16e-03 | 1372 | 34 | 10 | MP:0005382 |
| MousePheno | abnormal otic capsule morphology | 1.17e-03 | 21 | 34 | 2 | MP:0000039 | |
| MousePheno | myocardium hypoplasia | 1.17e-03 | 86 | 34 | 3 | MP:0010500 | |
| MousePheno | abnormal megakaryocyte morphology | 1.17e-03 | 86 | 34 | 3 | MP:0002417 | |
| MousePheno | abnormal rib joint morphology | 1.17e-03 | 86 | 34 | 3 | MP:0004625 | |
| MousePheno | abnormal facial morphology | 1.24e-03 | 910 | 34 | 8 | MP:0003743 | |
| MousePheno | absent myocardial trabeculae | 1.29e-03 | 22 | 34 | 2 | MP:0000293 | |
| MousePheno | abnormal extraembryonic tissue physiology | 1.37e-03 | 345 | 34 | 5 | MP:0004264 | |
| MousePheno | embryonic growth arrest | 1.39e-03 | 346 | 34 | 5 | MP:0001730 | |
| MousePheno | decreased midbrain size | 1.41e-03 | 23 | 34 | 2 | MP:0012089 | |
| MousePheno | abnormal placenta physiology | 1.45e-03 | 204 | 34 | 4 | MP:0010038 | |
| MousePheno | cerebellum hypoplasia | 1.53e-03 | 24 | 34 | 2 | MP:0000851 | |
| MousePheno | oliguria | 1.53e-03 | 24 | 34 | 2 | MP:0003620 | |
| MousePheno | small premaxilla | 1.66e-03 | 25 | 34 | 2 | MP:0004870 | |
| MousePheno | abnormal circulating hormone level | 1.68e-03 | 954 | 34 | 8 | MP:0005418 | |
| MousePheno | abnormal embryo size | 1.71e-03 | 956 | 34 | 8 | MP:0001697 | |
| MousePheno | ventricular hypoplasia | 1.76e-03 | 99 | 34 | 3 | MP:0000279 | |
| MousePheno | abnormal vascular development | 1.76e-03 | 542 | 34 | 6 | MP:0000259 | |
| MousePheno | abnormal hypothalamus physiology | 1.80e-03 | 26 | 34 | 2 | MP:0005645 | |
| MousePheno | conjunctivitis | 1.80e-03 | 26 | 34 | 2 | MP:0001852 | |
| MousePheno | abnormal bone marrow hematopoietic cell morphology | 1.92e-03 | 102 | 34 | 3 | MP:0013660 | |
| MousePheno | testis hypoplasia | 1.94e-03 | 27 | 34 | 2 | MP:0001940 | |
| MousePheno | heart hypoplasia | 1.97e-03 | 103 | 34 | 3 | MP:0002740 | |
| MousePheno | abnormal blood vessel morphology | NCOA2 NCOA6 ZFAND5 ARID1B CHD7 ARID1A SS18 CREBBP YAP1 EP300 | 1.99e-03 | 1472 | 34 | 10 | MP:0001614 |
| MousePheno | delayed vaginal opening | 2.09e-03 | 28 | 34 | 2 | MP:0002636 | |
| MousePheno | abnormal spongiotrophoblast size | 2.09e-03 | 28 | 34 | 2 | MP:0012097 | |
| MousePheno | decreased birth body size | 2.32e-03 | 232 | 34 | 4 | MP:0009703 | |
| MousePheno | abnormal gland development | 2.36e-03 | 233 | 34 | 4 | MP:0020973 | |
| MousePheno | increased long bone epiphyseal plate size | 2.39e-03 | 30 | 34 | 2 | MP:0006398 | |
| MousePheno | abnormal developmental patterning | 2.41e-03 | 577 | 34 | 6 | MP:0002084 | |
| MousePheno | abnormal vitelline vasculature morphology | 2.43e-03 | 235 | 34 | 4 | MP:0003229 | |
| Domain | Nuc_rcpt_coact | 1.82e-13 | 6 | 39 | 5 | IPR009110 | |
| Domain | DUF1518 | 8.42e-09 | 3 | 39 | 3 | PF07469 | |
| Domain | DUF1518 | 8.42e-09 | 3 | 39 | 3 | IPR010011 | |
| Domain | Src1_rcpt_coact | 8.42e-09 | 3 | 39 | 3 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 8.42e-09 | 3 | 39 | 3 | IPR017426 | |
| Domain | DUF1518 | 8.42e-09 | 3 | 39 | 3 | SM01151 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 8.42e-09 | 3 | 39 | 3 | IPR014920 | |
| Domain | SRC-1 | 8.42e-09 | 3 | 39 | 3 | IPR014935 | |
| Domain | SRC-1 | 8.42e-09 | 3 | 39 | 3 | PF08832 | |
| Domain | - | 8.42e-09 | 3 | 39 | 3 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 8.42e-09 | 3 | 39 | 3 | PF08815 | |
| Domain | - | 4.25e-06 | 2 | 39 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 4.25e-06 | 2 | 39 | 2 | PF02135 | |
| Domain | ZF_TAZ | 4.25e-06 | 2 | 39 | 2 | PS50134 | |
| Domain | BAF250_C | 4.25e-06 | 2 | 39 | 2 | IPR033388 | |
| Domain | Nuc_rcpt_coact_CREBbp | 4.25e-06 | 2 | 39 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 4.25e-06 | 2 | 39 | 2 | PF08214 | |
| Domain | BAF250_C | 4.25e-06 | 2 | 39 | 2 | PF12031 | |
| Domain | KIX | 4.25e-06 | 2 | 39 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 4.25e-06 | 2 | 39 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 4.25e-06 | 2 | 39 | 2 | IPR031162 | |
| Domain | DUF4927 | 4.25e-06 | 2 | 39 | 2 | PF16279 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 4.25e-06 | 2 | 39 | 2 | IPR013178 | |
| Domain | DUF902 | 4.25e-06 | 2 | 39 | 2 | PF06001 | |
| Domain | BAF250/Osa | 4.25e-06 | 2 | 39 | 2 | IPR021906 | |
| Domain | - | 4.25e-06 | 2 | 39 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 4.25e-06 | 2 | 39 | 2 | IPR010303 | |
| Domain | KAT11 | 4.25e-06 | 2 | 39 | 2 | SM01250 | |
| Domain | - | 4.25e-06 | 2 | 39 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 4.25e-06 | 2 | 39 | 2 | IPR000197 | |
| Domain | KIX_dom | 4.25e-06 | 2 | 39 | 2 | IPR003101 | |
| Domain | Creb_binding | 4.25e-06 | 2 | 39 | 2 | PF09030 | |
| Domain | DUF4927 | 4.25e-06 | 2 | 39 | 2 | IPR032565 | |
| Domain | KIX | 4.25e-06 | 2 | 39 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 4.25e-06 | 2 | 39 | 2 | PS51727 | |
| Domain | PAS | 1.88e-05 | 25 | 39 | 3 | PF00989 | |
| Domain | PAS_fold | 1.88e-05 | 25 | 39 | 3 | IPR013767 | |
| Domain | PAS | 4.00e-05 | 32 | 39 | 3 | SM00091 | |
| Domain | PAS | 4.82e-05 | 34 | 39 | 3 | IPR000014 | |
| Domain | PAS | 4.82e-05 | 34 | 39 | 3 | PS50112 | |
| Domain | - | 4.39e-04 | 15 | 39 | 2 | 1.10.150.60 | |
| Domain | ARID | 4.39e-04 | 15 | 39 | 2 | PF01388 | |
| Domain | BRIGHT | 4.39e-04 | 15 | 39 | 2 | SM00501 | |
| Domain | ARID_dom | 4.39e-04 | 15 | 39 | 2 | IPR001606 | |
| Domain | ARID | 4.39e-04 | 15 | 39 | 2 | PS51011 | |
| Domain | ZF_ZZ_2 | 6.36e-04 | 18 | 39 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.36e-04 | 18 | 39 | 2 | PS01357 | |
| Domain | ZZ | 6.36e-04 | 18 | 39 | 2 | PF00569 | |
| Domain | Znf_ZZ | 7.10e-04 | 19 | 39 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 7.10e-04 | 19 | 39 | 2 | SM00291 | |
| Domain | Bromodomain_CS | 1.34e-03 | 26 | 39 | 2 | IPR018359 | |
| Domain | - | 1.52e-03 | 109 | 39 | 3 | 4.10.280.10 | |
| Domain | HLH | 1.81e-03 | 116 | 39 | 3 | SM00353 | |
| Domain | BHLH | 1.86e-03 | 117 | 39 | 3 | PS50888 | |
| Domain | bHLH_dom | 1.90e-03 | 118 | 39 | 3 | IPR011598 | |
| Domain | BROMODOMAIN_1 | 2.70e-03 | 37 | 39 | 2 | PS00633 | |
| Domain | Bromodomain | 2.85e-03 | 38 | 39 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 3.31e-03 | 41 | 39 | 2 | PS50014 | |
| Domain | BROMO | 3.47e-03 | 42 | 39 | 2 | SM00297 | |
| Domain | Bromodomain | 3.47e-03 | 42 | 39 | 2 | IPR001487 | |
| Domain | - | 3.47e-03 | 42 | 39 | 2 | 1.20.920.10 | |
| Domain | UBA-like | 7.89e-03 | 64 | 39 | 2 | IPR009060 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.58e-10 | 18 | 30 | 5 | M26942 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 4.22e-09 | 30 | 30 | 5 | M207 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.64e-08 | 14 | 30 | 4 | M27808 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.98e-08 | 84 | 30 | 6 | M1008 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.98e-08 | 16 | 30 | 4 | M27121 | |
| Pathway | REACTOME_HEME_SIGNALING | 5.49e-08 | 49 | 30 | 5 | M41832 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.88e-08 | 20 | 30 | 4 | M27881 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 9.93e-08 | 55 | 30 | 5 | M27001 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.00e-07 | 110 | 30 | 6 | M48259 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.19e-07 | 22 | 30 | 4 | MM1370 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.53e-07 | 118 | 30 | 6 | M27316 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.72e-07 | 24 | 30 | 4 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.04e-07 | 25 | 30 | 4 | M27880 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 2.83e-07 | 27 | 30 | 4 | M26943 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 3.38e-07 | 70 | 30 | 5 | M938 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.84e-07 | 8 | 30 | 3 | M22058 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 6.07e-07 | 149 | 30 | 6 | M27888 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.03e-06 | 10 | 30 | 3 | MM15535 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.26e-06 | 91 | 30 | 5 | M39700 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 1.42e-06 | 11 | 30 | 3 | M47503 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.64e-06 | 96 | 30 | 5 | M27784 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.76e-06 | 42 | 30 | 4 | M17541 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 1.76e-06 | 42 | 30 | 4 | M27172 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.89e-06 | 12 | 30 | 3 | M27159 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.13e-06 | 44 | 30 | 4 | M27295 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B ARID1A SS18 CREBBP YAP1 EP300 MAMLD1 TNRC6A | 2.65e-06 | 1432 | 30 | 13 | M509 |
| Pathway | PID_HES_HEY_PATHWAY | 3.04e-06 | 48 | 30 | 4 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.04e-06 | 48 | 30 | 4 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.30e-06 | 49 | 30 | 4 | M618 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 3.89e-06 | 15 | 30 | 3 | M119 | |
| Pathway | PID_AR_TF_PATHWAY | 4.54e-06 | 53 | 30 | 4 | M151 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.74e-06 | 119 | 30 | 5 | M607 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 5.27e-06 | 55 | 30 | 4 | M27145 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 5.80e-06 | 17 | 30 | 3 | M48025 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 5.86e-06 | 220 | 30 | 6 | M27794 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 6.53e-06 | 58 | 30 | 4 | M29616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.95e-06 | 18 | 30 | 3 | MM14775 | |
| Pathway | REACTOME_GASTRULATION | 7.04e-06 | 129 | 30 | 5 | M46433 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 7.48e-06 | 60 | 30 | 4 | M41830 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 8.97e-06 | 237 | 30 | 6 | M27786 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 9.44e-06 | 137 | 30 | 5 | M48232 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 9.69e-06 | 64 | 30 | 4 | M200 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.10e-05 | 66 | 30 | 4 | M255 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.31e-05 | 69 | 30 | 4 | M46439 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.67e-05 | 154 | 30 | 5 | M27832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.73e-05 | 74 | 30 | 4 | M616 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.92e-05 | 76 | 30 | 4 | MM15520 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.96e-05 | 272 | 30 | 6 | M29619 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 2.60e-05 | 82 | 30 | 4 | M594 | |
| Pathway | PID_REG_GR_PATHWAY | 2.60e-05 | 82 | 30 | 4 | M115 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.60e-05 | 82 | 30 | 4 | M2 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.75e-05 | 28 | 30 | 3 | M6177 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.06e-05 | 29 | 30 | 3 | M48076 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 3.16e-05 | 296 | 30 | 6 | M27869 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 3.76e-05 | 31 | 30 | 3 | M39476 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 3.76e-05 | 31 | 30 | 3 | M39522 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 4.14e-05 | 32 | 30 | 3 | M39567 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.36e-05 | 5 | 30 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 4.36e-05 | 5 | 30 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 4.36e-05 | 5 | 30 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 4.36e-05 | 5 | 30 | 2 | M48023 | |
| Pathway | KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 4.36e-05 | 5 | 30 | 2 | M48983 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 4.55e-05 | 33 | 30 | 3 | M604 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 4.64e-05 | 95 | 30 | 4 | M48268 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 4.83e-05 | 96 | 30 | 4 | M26973 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 5.67e-05 | 100 | 30 | 4 | MM15826 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 6.44e-05 | 37 | 30 | 3 | M27797 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 6.44e-05 | 37 | 30 | 3 | M29790 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 6.53e-05 | 6 | 30 | 2 | M22062 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 7.36e-05 | 210 | 30 | 5 | M41836 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 7.55e-05 | 39 | 30 | 3 | MM14604 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 9.13e-05 | 7 | 30 | 2 | MM1573 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 9.44e-05 | 42 | 30 | 3 | M48237 | |
| Pathway | PID_HNF3A_PATHWAY | 1.09e-04 | 44 | 30 | 3 | M285 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.22e-04 | 8 | 30 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.22e-04 | 8 | 30 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.22e-04 | 8 | 30 | 2 | M46443 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.23e-04 | 122 | 30 | 4 | M29689 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.32e-04 | 47 | 30 | 3 | M7946 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.32e-04 | 47 | 30 | 3 | M29777 | |
| Pathway | PID_FOXO_PATHWAY | 1.50e-04 | 49 | 30 | 3 | M136 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.55e-04 | 246 | 30 | 5 | M10189 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.56e-04 | 9 | 30 | 2 | M47451 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.79e-04 | 52 | 30 | 3 | M2404 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.80e-04 | 254 | 30 | 5 | M27131 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.95e-04 | 10 | 30 | 2 | M27945 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 2.21e-04 | 142 | 30 | 4 | M27233 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.38e-04 | 11 | 30 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.38e-04 | 11 | 30 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.38e-04 | 11 | 30 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.85e-04 | 12 | 30 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.85e-04 | 12 | 30 | 2 | M27765 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.17e-04 | 63 | 30 | 3 | MM15613 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION | 3.37e-04 | 13 | 30 | 2 | M47595 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.37e-04 | 13 | 30 | 2 | MM15622 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.48e-04 | 65 | 30 | 3 | M39682 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 3.73e-04 | 464 | 30 | 6 | M27547 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.92e-04 | 14 | 30 | 2 | M27074 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.92e-04 | 14 | 30 | 2 | MM14748 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 4.52e-04 | 15 | 30 | 2 | MM1339 | |
| Pubmed | MAML1 NCOA2 NCOA1 NCOA3 RBM12 SSBP3 CREBBP EP300 TAB3 TNRC6A | 1.07e-15 | 152 | 39 | 10 | 38360978 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | MAML1 NCOA2 NCOA3 NCOA6 ARID1B RBM12 ARID1A CREBBP GLI1 EP300 MAMLD1 TNRC6A NCOA5 | 1.75e-15 | 457 | 39 | 13 | 32344865 |
| Pubmed | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 RBM12 ARID1A CREBBP YAP1 | 6.41e-15 | 268 | 39 | 11 | 33640491 | |
| Pubmed | 5.09e-14 | 20 | 39 | 6 | 11877444 | ||
| Pubmed | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 RBM12 SSBP3 ARID1A SS18 CREBBP YAP1 EP300 TAB3 HGS TNRC6A | 5.34e-14 | 1429 | 39 | 17 | 35140242 | |
| Pubmed | 7.12e-14 | 21 | 39 | 6 | 19596656 | ||
| Pubmed | 3.14e-12 | 78 | 39 | 7 | 28611094 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 ARID1A CREBBP EP300 | 4.73e-12 | 351 | 39 | 10 | 38297188 |
| Pubmed | 4.92e-12 | 83 | 39 | 7 | 28794006 | ||
| Pubmed | 6.74e-12 | 5 | 39 | 4 | 12714702 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 6.74e-12 | 5 | 39 | 4 | 9812974 | |
| Pubmed | 8.32e-12 | 17 | 39 | 5 | 19183483 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 2.02e-11 | 6 | 39 | 4 | 11076796 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 16923966 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 4.71e-11 | 7 | 39 | 4 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 4.71e-11 | 7 | 39 | 4 | 9192892 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 4.71e-11 | 7 | 39 | 4 | 9590696 | |
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 12709428 | ||
| Pubmed | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 ARID1A SS18 CREBBP EP300 | 7.65e-11 | 638 | 39 | 11 | 31182584 | |
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 12082103 | ||
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 9.42e-11 | 8 | 39 | 4 | 11971985 | |
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 17475621 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 10490106 | ||
| Pubmed | 1.31e-10 | 28 | 39 | 5 | 24880616 | ||
| Pubmed | 4.43e-10 | 11 | 39 | 4 | 36613751 | ||
| Pubmed | 4.55e-10 | 157 | 39 | 7 | 30186101 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.81e-10 | 398 | 39 | 9 | 35016035 | |
| Pubmed | 6.64e-10 | 12 | 39 | 4 | 12189208 | ||
| Pubmed | 9.58e-10 | 13 | 39 | 4 | 11266503 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 21035760 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 21059860 | ||
| Pubmed | Absence of the steroid receptor coactivator-3 induces B-cell lymphoma. | 1.30e-09 | 3 | 39 | 3 | 16675958 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 9506940 | ||
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 1.30e-09 | 3 | 39 | 3 | 12050117 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 28390937 | ||
| Pubmed | Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. | 1.30e-09 | 3 | 39 | 3 | 23927929 | |
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 1.30e-09 | 3 | 39 | 3 | 11823864 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 18845648 | ||
| Pubmed | The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. | 1.30e-09 | 3 | 39 | 3 | 12138202 | |
| Pubmed | Structure and chromosomal locations of mouse steroid receptor coactivator gene family. | 1.30e-09 | 3 | 39 | 3 | 10501088 | |
| Pubmed | The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. | 1.30e-09 | 3 | 39 | 3 | 16423883 | |
| Pubmed | 1.34e-09 | 14 | 39 | 4 | 12482968 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 1.34e-09 | 14 | 39 | 4 | 11500849 | |
| Pubmed | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 RBM12 ARID1A CREBBP EP300 PPP4R2 | 1.73e-09 | 1103 | 39 | 12 | 34189442 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.77e-09 | 220 | 39 | 7 | 35785414 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 26066330 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 10551785 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 16227615 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 33589584 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 18267973 | ||
| Pubmed | Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells. | 5.21e-09 | 4 | 39 | 3 | 15331759 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 12208951 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 11463834 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 19095746 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 5.21e-09 | 4 | 39 | 3 | 10655477 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 11113179 | ||
| Pubmed | Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. | 5.21e-09 | 4 | 39 | 3 | 22560224 | |
| Pubmed | A simple method to screen ligands of peroxisome proliferator-activated receptor delta. | 5.21e-09 | 4 | 39 | 3 | 16930961 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 26267537 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 11701890 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 15449938 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 15563453 | ||
| Pubmed | 5.45e-09 | 57 | 39 | 5 | 18022353 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 10652338 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 17950690 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 17476305 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 17854779 | ||
| Pubmed | Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes. | 1.30e-08 | 5 | 39 | 3 | 18511550 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 14766010 | ||
| Pubmed | Transcription factor-specific requirements for coactivators and their acetyltransferase functions. | 1.30e-08 | 5 | 39 | 3 | 9445475 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 10381882 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 14722092 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 12514218 | ||
| Pubmed | Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. | 1.30e-08 | 5 | 39 | 3 | 11376110 | |
| Pubmed | Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. | 1.30e-08 | 5 | 39 | 3 | 18798693 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 12554772 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 11912212 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 10757795 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 10224118 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 10803578 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 16373399 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 12630920 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 10777539 | ||
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 2.60e-08 | 6 | 39 | 3 | 15615775 | |
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 10973497 | ||
| Pubmed | Roles of coactivators in hypoxic induction of the erythropoietin gene. | 2.60e-08 | 6 | 39 | 3 | 20368990 | |
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 16728408 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 10497212 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 15731352 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 4.17e-08 | 85 | 39 | 5 | 16051665 | |
| Pubmed | 4.55e-08 | 7 | 39 | 3 | 21195347 | ||
| Pubmed | Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. | 4.55e-08 | 7 | 39 | 3 | 11117530 | |
| Pubmed | 4.55e-08 | 7 | 39 | 3 | 23540691 | ||
| Pubmed | 4.55e-08 | 7 | 39 | 3 | 16332960 | ||
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 11050077 | ||
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 8616895 | ||
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 14747462 | ||
| Pubmed | Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. | 7.27e-08 | 8 | 39 | 3 | 12145209 | |
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 23178929 | ||
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 9346901 | ||
| Interaction | TBXT interactions | MAML1 NCOA2 NCOA3 NCOA6 ARID1B CHD7 SSBP3 ARID1A SS18 CREBBP YAP1 EP300 | 2.53e-18 | 116 | 39 | 12 | int:TBXT |
| Interaction | SP7 interactions | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 RBM12 SSBP3 ARID1A SS18 CREBBP EP300 | 9.26e-15 | 304 | 39 | 13 | int:SP7 |
| Interaction | SOX7 interactions | 3.73e-14 | 82 | 39 | 9 | int:SOX7 | |
| Interaction | FEV interactions | MAML1 NCOA2 NCOA3 NCOA6 ARID1B CHD7 SSBP3 ARID1A CREBBP YAP1 EP300 | 1.08e-13 | 203 | 39 | 11 | int:FEV |
| Interaction | PAX8 interactions | 6.19e-13 | 111 | 39 | 9 | int:PAX8 | |
| Interaction | NUP35 interactions | MAML1 NCOA2 NCOA3 NCOA6 ARID1B RBM12 ARID1A CREBBP GLI1 EP300 MAMLD1 TNRC6A NCOA5 | 6.52e-13 | 424 | 39 | 13 | int:NUP35 |
| Interaction | EGR2 interactions | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 ARID1A CREBBP EP300 | 7.63e-13 | 171 | 39 | 10 | int:EGR2 |
| Interaction | EYA4 interactions | MAML1 NCOA2 NCOA1 NCOA3 ERBB3 RBM12 SSBP3 CREBBP EP300 TAB3 TNRC6A | 7.77e-13 | 243 | 39 | 11 | int:EYA4 |
| Interaction | PAX7 interactions | 1.71e-12 | 124 | 39 | 9 | int:PAX7 | |
| Interaction | KLF5 interactions | MAML1 NCOA2 NCOA3 NCOA6 ARID1B ARID1A SS18 CREBBP YAP1 EP300 | 2.84e-12 | 195 | 39 | 10 | int:KLF5 |
| Interaction | SMARCE1 interactions | NCOA2 NCOA1 NCOA3 ARID1B CHD7 SSBP3 ARID1A SS18 YAP1 GLI1 EP300 | 4.75e-12 | 287 | 39 | 11 | int:SMARCE1 |
| Interaction | ERG interactions | MAML1 NCOA2 NCOA3 NCOA6 ARID1B CHD7 ARID1A SS18 CREBBP EP300 | 1.08e-11 | 223 | 39 | 10 | int:ERG |
| Interaction | SMG7 interactions | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B RBM12 ARID1A CREBBP SAMD4B TNRC6A | 1.49e-11 | 319 | 39 | 11 | int:SMG7 |
| Interaction | TLX1 interactions | 3.87e-11 | 175 | 39 | 9 | int:TLX1 | |
| Interaction | CRX interactions | 3.91e-11 | 254 | 39 | 10 | int:CRX | |
| Interaction | TBR1 interactions | 4.05e-11 | 113 | 39 | 8 | int:TBR1 | |
| Interaction | ETV4 interactions | 5.69e-11 | 69 | 39 | 7 | int:ETV4 | |
| Interaction | ALG13 interactions | 5.77e-11 | 183 | 39 | 9 | int:ALG13 | |
| Interaction | HNF1B interactions | 8.08e-11 | 190 | 39 | 9 | int:HNF1B | |
| Interaction | HNF4A interactions | NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 ARID1A SS18 CREBBP EP300 | 8.53e-11 | 275 | 39 | 10 | int:HNF4A |
| Interaction | GATA2 interactions | 1.22e-10 | 199 | 39 | 9 | int:GATA2 | |
| Interaction | PAX9 interactions | 1.25e-10 | 130 | 39 | 8 | int:PAX9 | |
| Interaction | IRF4 interactions | 2.55e-10 | 85 | 39 | 7 | int:IRF4 | |
| Interaction | FOS interactions | NCOA2 NCOA1 NCOA3 NCOA6 ARID1B ARID1A SS18 CREBBP EP300 CREB5 | 2.93e-10 | 312 | 39 | 10 | int:FOS |
| Interaction | NR1I2 interactions | 4.06e-10 | 48 | 39 | 6 | int:NR1I2 | |
| Interaction | FOXI1 interactions | 4.47e-10 | 92 | 39 | 7 | int:FOXI1 | |
| Interaction | SMAD3 interactions | ZCCHC14 NCOA1 NCOA3 NCOA6 ARID1B TOB1 ARID1A CREBBP YAP1 EP300 HGS | 5.42e-10 | 447 | 39 | 11 | int:SMAD3 |
| Interaction | SOX17 interactions | 5.62e-10 | 95 | 39 | 7 | int:SOX17 | |
| Interaction | SOX9 interactions | 6.51e-10 | 97 | 39 | 7 | int:SOX9 | |
| Interaction | SS18L1 interactions | 7.01e-10 | 98 | 39 | 7 | int:SS18L1 | |
| Interaction | SMARCA4 interactions | MAML1 NCOA1 ARID1B CHD7 SSBP3 ARID1A SS18 CREBBP YAP1 GLI1 EP300 | 7.67e-10 | 462 | 39 | 11 | int:SMARCA4 |
| Interaction | SMARCC2 interactions | 9.69e-10 | 353 | 39 | 10 | int:SMARCC2 | |
| Interaction | TEAD1 interactions | 1.41e-09 | 176 | 39 | 8 | int:TEAD1 | |
| Interaction | TLE3 interactions | MAML1 NCOA2 NCOA1 NCOA3 ARID1B RBM12 ARID1A CREBBP EP300 TNRC6A | 1.78e-09 | 376 | 39 | 10 | int:TLE3 |
| Interaction | ARID1A interactions | 2.20e-09 | 276 | 39 | 9 | int:ARID1A | |
| Interaction | SMAD2 interactions | 2.24e-09 | 385 | 39 | 10 | int:SMAD2 | |
| Interaction | NFIA interactions | 2.37e-09 | 188 | 39 | 8 | int:NFIA | |
| Interaction | MYOD1 interactions | 3.04e-09 | 194 | 39 | 8 | int:MYOD1 | |
| Interaction | TLX3 interactions | 3.50e-09 | 291 | 39 | 9 | int:TLX3 | |
| Interaction | GCM1 interactions | 3.52e-09 | 68 | 39 | 6 | int:GCM1 | |
| Interaction | NCOA6 interactions | 1.09e-08 | 145 | 39 | 7 | int:NCOA6 | |
| Interaction | NCOA1 interactions | 1.15e-08 | 146 | 39 | 7 | int:NCOA1 | |
| Interaction | SOX10 interactions | 2.22e-08 | 92 | 39 | 6 | int:SOX10 | |
| Interaction | SMARCB1 interactions | 2.44e-08 | 364 | 39 | 9 | int:SMARCB1 | |
| Interaction | SMARCC1 interactions | 3.86e-08 | 384 | 39 | 9 | int:SMARCC1 | |
| Interaction | GATA3 interactions | 6.33e-08 | 187 | 39 | 7 | int:GATA3 | |
| Interaction | THRA interactions | 6.85e-08 | 111 | 39 | 6 | int:THRA | |
| Interaction | KLF15 interactions | 6.97e-08 | 290 | 39 | 8 | int:KLF15 | |
| Interaction | TPRX2 interactions | 7.39e-08 | 56 | 39 | 5 | int:TPRX2 | |
| Interaction | RARG interactions | 8.84e-08 | 58 | 39 | 5 | int:RARG | |
| Interaction | ETS1 interactions | 1.15e-07 | 121 | 39 | 6 | int:ETS1 | |
| Interaction | CREBBP interactions | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B ARID1A CREBBP YAP1 EP300 | 1.46e-07 | 599 | 39 | 10 | int:CREBBP |
| Interaction | TLE6 interactions | 1.47e-07 | 25 | 39 | 4 | int:TLE6 | |
| Interaction | VDR interactions | 1.53e-07 | 127 | 39 | 6 | int:VDR | |
| Interaction | RARA interactions | 2.10e-07 | 223 | 39 | 7 | int:RARA | |
| Interaction | JUN interactions | 2.15e-07 | 470 | 39 | 9 | int:JUN | |
| Interaction | AR interactions | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 RBM12 ARID1A CREBBP YAP1 EP300 | 2.16e-07 | 992 | 39 | 12 | int:AR |
| Interaction | SOX15 interactions | 2.84e-07 | 141 | 39 | 6 | int:SOX15 | |
| Interaction | NCOA2 interactions | 2.84e-07 | 141 | 39 | 6 | int:NCOA2 | |
| Interaction | NFIB interactions | 2.97e-07 | 142 | 39 | 6 | int:NFIB | |
| Interaction | CEBPA interactions | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 RBM12 ARID1A CREBBP EP300 PPP4R2 NCOA5 | 3.21e-07 | 1245 | 39 | 13 | int:CEBPA |
| Interaction | ELF5 interactions | 3.64e-07 | 147 | 39 | 6 | int:ELF5 | |
| Interaction | SMAD1 interactions | 3.76e-07 | 243 | 39 | 7 | int:SMAD1 | |
| Interaction | PAX6 interactions | 4.13e-07 | 366 | 39 | 8 | int:PAX6 | |
| Interaction | IRF1 interactions | 5.41e-07 | 83 | 39 | 5 | int:IRF1 | |
| Interaction | PGR interactions | 5.74e-07 | 84 | 39 | 5 | int:PGR | |
| Interaction | KLF4 interactions | 5.99e-07 | 160 | 39 | 6 | int:KLF4 | |
| Interaction | TP53BP1 interactions | 6.18e-07 | 533 | 39 | 9 | int:TP53BP1 | |
| Interaction | E2F5 interactions | 6.74e-07 | 36 | 39 | 4 | int:E2F5 | |
| Interaction | HOXB2 interactions | 6.74e-07 | 36 | 39 | 4 | int:HOXB2 | |
| Interaction | STAT6 interactions | 6.85e-07 | 87 | 39 | 5 | int:STAT6 | |
| Interaction | RXRA interactions | 8.25e-07 | 169 | 39 | 6 | int:RXRA | |
| Interaction | PPARA interactions | 9.05e-07 | 92 | 39 | 5 | int:PPARA | |
| Interaction | RORA interactions | 9.38e-07 | 39 | 39 | 4 | int:RORA | |
| Interaction | RBCK1 interactions | 1.05e-06 | 176 | 39 | 6 | int:RBCK1 | |
| Interaction | ARID1B interactions | 1.08e-06 | 177 | 39 | 6 | int:ARID1B | |
| Interaction | SUMO1 interactions | 1.15e-06 | 287 | 39 | 7 | int:SUMO1 | |
| Interaction | WWTR1 interactions | 1.20e-06 | 422 | 39 | 8 | int:WWTR1 | |
| Interaction | NPAS2 interactions | 1.27e-06 | 42 | 39 | 4 | int:NPAS2 | |
| Interaction | LHX3 interactions | 1.40e-06 | 185 | 39 | 6 | int:LHX3 | |
| Interaction | THRB interactions | 1.44e-06 | 186 | 39 | 6 | int:THRB | |
| Interaction | SOX2 interactions | MAML1 NCOA2 NCOA3 NCOA6 ARID1B CHD7 SSBP3 ARID1A SS18 YAP1 EP300 SAMD4B TNRC6A | 1.46e-06 | 1422 | 39 | 13 | int:SOX2 |
| Interaction | NR3C1 interactions | MAML1 NCOA2 NCOA1 NCOA3 NCOA6 ARID1B CHD7 ARID1A SS18 CREBBP EP300 | 1.53e-06 | 974 | 39 | 11 | int:NR3C1 |
| Interaction | PPARG interactions | 1.80e-06 | 307 | 39 | 7 | int:PPARG | |
| Interaction | RARB interactions | 1.84e-06 | 46 | 39 | 4 | int:RARB | |
| Interaction | CNOT3 interactions | 2.69e-06 | 207 | 39 | 6 | int:CNOT3 | |
| Interaction | DDIT3 interactions | 3.37e-06 | 120 | 39 | 5 | int:DDIT3 | |
| Interaction | CIITA interactions | 3.80e-06 | 55 | 39 | 4 | int:CIITA | |
| Interaction | NCOA3 interactions | 4.23e-06 | 224 | 39 | 6 | int:NCOA3 | |
| Interaction | MAML2 interactions | 4.47e-06 | 17 | 39 | 3 | int:MAML2 | |
| Interaction | NR1H3 interactions | 4.71e-06 | 58 | 39 | 4 | int:NR1H3 | |
| Interaction | ETS2 interactions | 5.77e-06 | 61 | 39 | 4 | int:ETS2 | |
| Interaction | NR1H2 interactions | 8.92e-06 | 68 | 39 | 4 | int:NR1H2 | |
| Interaction | ARID2 interactions | 1.10e-05 | 153 | 39 | 5 | int:ARID2 | |
| Interaction | ASH2L interactions | 1.11e-05 | 265 | 39 | 6 | int:ASH2L | |
| Interaction | MED23 interactions | 1.13e-05 | 266 | 39 | 6 | int:MED23 | |
| Interaction | SUPT5H interactions | 1.16e-05 | 408 | 39 | 7 | int:SUPT5H | |
| Interaction | SOX6 interactions | 1.25e-05 | 157 | 39 | 5 | int:SOX6 | |
| Interaction | MDC1 interactions | 1.28e-05 | 414 | 39 | 7 | int:MDC1 | |
| Interaction | NR6A1 interactions | 1.32e-05 | 24 | 39 | 3 | int:NR6A1 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.73e-11 | 17 | 28 | 5 | 486 | |
| GeneFamily | AT-rich interaction domain containing | 2.40e-04 | 15 | 28 | 2 | 418 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.48e-04 | 18 | 28 | 2 | 91 | |
| GeneFamily | Basic helix-loop-helix proteins | 6.43e-04 | 110 | 28 | 3 | 420 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.79e-04 | 25 | 28 | 2 | 775 | |
| GeneFamily | Sterile alpha motif domain containing | 8.15e-03 | 88 | 28 | 2 | 760 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 NCOA1 NCOA3 SEC24D RGS20 CREBBP YAP1 CREB5 TRAK1 MAMLD1 | 3.52e-07 | 856 | 39 | 10 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.05e-06 | 466 | 39 | 7 | M13522 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 1.01e-05 | 195 | 39 | 5 | M4201 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 1.12e-05 | 199 | 39 | 5 | M9255 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 1.15e-05 | 200 | 39 | 5 | M8030 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D5 | 1.93e-05 | 35 | 39 | 3 | M13814 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 2.35e-05 | 822 | 39 | 8 | M6782 | |
| Coexpression | DESCARTES_ORGANOGENESIS_PREMATURE_OLIGODENDROCYTE | 2.90e-05 | 40 | 39 | 3 | MM3636 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 5.73e-05 | 680 | 39 | 7 | M41089 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 6.00e-05 | 685 | 39 | 7 | MM3782 | |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 6.78e-05 | 53 | 39 | 3 | M6303 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 7.23e-05 | 294 | 39 | 5 | M40873 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 7.95e-05 | 300 | 39 | 5 | M8702 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 1.11e-04 | 322 | 39 | 5 | MM3786 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.47e-04 | 180 | 39 | 4 | M8239 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP | 1.77e-04 | 189 | 39 | 4 | M4199 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN | 1.99e-04 | 195 | 39 | 4 | M9824 | |
| Coexpression | GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN | 2.07e-04 | 197 | 39 | 4 | M4720 | |
| Coexpression | GSE28408_LY6G_POS_VS_NEG_DC_UP | 2.07e-04 | 197 | 39 | 4 | M9547 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN | 2.11e-04 | 198 | 39 | 4 | M3550 | |
| Coexpression | GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 2.11e-04 | 198 | 39 | 4 | M4247 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 2.20e-04 | 200 | 39 | 4 | M5069 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 2.20e-04 | 200 | 39 | 4 | M5059 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP | 2.20e-04 | 200 | 39 | 4 | M385 | |
| Coexpression | GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN | 2.20e-04 | 200 | 39 | 4 | M5837 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN | 2.20e-04 | 200 | 39 | 4 | M7028 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP | 2.20e-04 | 200 | 39 | 4 | M3648 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 2.20e-04 | 200 | 39 | 4 | M9847 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 2.20e-04 | 200 | 39 | 4 | M8506 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN | 2.20e-04 | 200 | 39 | 4 | M3864 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN | 2.20e-04 | 200 | 39 | 4 | M3885 | |
| Coexpression | GHANDHI_BYSTANDER_IRRADIATION_UP | 2.67e-04 | 84 | 39 | 3 | M2597 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 2.74e-04 | 212 | 39 | 4 | MM3816 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP | 2.86e-04 | 86 | 39 | 3 | M19610 | |
| Coexpression | LU_EZH2_TARGETS_DN | 3.03e-04 | 400 | 39 | 5 | M2140 | |
| Coexpression | AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2 | 3.10e-04 | 219 | 39 | 4 | M39111 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 3.72e-04 | 94 | 39 | 3 | M18108 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 4.33e-04 | 99 | 39 | 3 | M768 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 4.38e-04 | 240 | 39 | 4 | M39236 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 4.72e-04 | 102 | 39 | 3 | M2124 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 5.67e-04 | 705 | 39 | 6 | M1410 | |
| Coexpression | LU_AGING_BRAIN_UP | 6.18e-04 | 263 | 39 | 4 | M5547 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.20e-07 | 188 | 39 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 158 | 39 | 4 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.75e-05 | 178 | 39 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-05 | 186 | 39 | 4 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.08e-05 | 186 | 39 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.08e-05 | 186 | 39 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 2.40e-05 | 193 | 39 | 4 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | CV-Severe-6|Severe / Virus stimulation, Condition and Cluster | 2.45e-05 | 194 | 39 | 4 | d33be6ed1de907aeea0c2dce09796556b8efdd4e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 196 | 39 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-05 | 197 | 39 | 4 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 198 | 39 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-05 | 199 | 39 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-05 | 199 | 39 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.76e-05 | 200 | 39 | 4 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.23e-04 | 135 | 39 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.38e-04 | 138 | 39 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-04 | 139 | 39 | 3 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | Control-APC-like-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 2.64e-04 | 143 | 39 | 3 | ffc1f497245d559e97e40d1bc4ee14e1ef09040c | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.04e-04 | 150 | 39 | 3 | b30f52b94ce772632a1f2f5e0837db876cf92651 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.04e-04 | 150 | 39 | 3 | 05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-04 | 151 | 39 | 3 | 09405a450af3ea246d9685a6d3137dfaec80e9bf | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 156 | 39 | 3 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-04 | 157 | 39 | 3 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.09e-04 | 166 | 39 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Marrow-BM-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | 8e7a30eb546fc6fa184ebb76f54b74b278005a84 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 4.69e-04 | 174 | 39 | 3 | 8273de40552d1cca1a8fe3647fd5e4cb4bb70f99 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.69e-04 | 174 | 39 | 3 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.69e-04 | 174 | 39 | 3 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.77e-04 | 175 | 39 | 3 | 63e977b8bafae1c5f742fc35a4cc712fefa9727f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 176 | 39 | 3 | ac3dc44755280e36c0947b6de3cd639dc17de8b6 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.85e-04 | 176 | 39 | 3 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 4.93e-04 | 177 | 39 | 3 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | 35d42b07d9c31528bf59199e361bb8a3bfbe3b75 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 178 | 39 | 3 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 178 | 39 | 3 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 5.01e-04 | 178 | 39 | 3 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 5.35e-04 | 182 | 39 | 3 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 182 | 39 | 3 | a00abff41c12b71d5860c494b8c722d649fd5f36 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 182 | 39 | 3 | 626aabfd9ac662c1d189f7c4b660482914d9e669 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-04 | 182 | 39 | 3 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-04 | 182 | 39 | 3 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-04 | 182 | 39 | 3 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-04 | 182 | 39 | 3 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.43e-04 | 183 | 39 | 3 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | Hippocampus-Macroglia|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.52e-04 | 184 | 39 | 3 | a1d039ddf1e2a87b870f3ce6d139be56090349df | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.52e-04 | 184 | 39 | 3 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.61e-04 | 185 | 39 | 3 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.61e-04 | 185 | 39 | 3 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.61e-04 | 185 | 39 | 3 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 185 | 39 | 3 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.61e-04 | 185 | 39 | 3 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-04 | 186 | 39 | 3 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 5.69e-04 | 186 | 39 | 3 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.69e-04 | 186 | 39 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 187 | 39 | 3 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 187 | 39 | 3 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 187 | 39 | 3 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.78e-04 | 187 | 39 | 3 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 187 | 39 | 3 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 5.78e-04 | 187 | 39 | 3 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.78e-04 | 187 | 39 | 3 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 187 | 39 | 3 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 187 | 39 | 3 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 187 | 39 | 3 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-04 | 188 | 39 | 3 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-04 | 188 | 39 | 3 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-04 | 188 | 39 | 3 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-04 | 188 | 39 | 3 | e7f58cd67afac441204c29676de2ffa7aaafd988 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-04 | 189 | 39 | 3 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.97e-04 | 189 | 39 | 3 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.97e-04 | 189 | 39 | 3 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 5.97e-04 | 189 | 39 | 3 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-04 | 189 | 39 | 3 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 5.97e-04 | 189 | 39 | 3 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.97e-04 | 189 | 39 | 3 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.97e-04 | 189 | 39 | 3 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.06e-04 | 190 | 39 | 3 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.06e-04 | 190 | 39 | 3 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.06e-04 | 190 | 39 | 3 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 6.06e-04 | 190 | 39 | 3 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 6.06e-04 | 190 | 39 | 3 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.06e-04 | 190 | 39 | 3 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.06e-04 | 190 | 39 | 3 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.15e-04 | 191 | 39 | 3 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.15e-04 | 191 | 39 | 3 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.15e-04 | 191 | 39 | 3 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.15e-04 | 191 | 39 | 3 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.15e-04 | 191 | 39 | 3 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 6.15e-04 | 191 | 39 | 3 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-04 | 192 | 39 | 3 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.24e-04 | 192 | 39 | 3 | 3fc7a661ef39286abfd82ed8ab580011f01cb8fd | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.24e-04 | 192 | 39 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-04 | 192 | 39 | 3 | b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.24e-04 | 192 | 39 | 3 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| Drug | Androstenedione | 1.31e-08 | 45 | 39 | 5 | ctd:D000735 | |
| Drug | butamben | 9.26e-08 | 6 | 39 | 3 | ctd:C004605 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.22e-07 | 170 | 39 | 6 | 1050_DN | |
| Drug | AC1L1COZ | 4.47e-07 | 90 | 39 | 5 | CID000001996 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.84e-07 | 174 | 39 | 6 | 1659_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 5.00e-07 | 175 | 39 | 6 | 1058_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 5.35e-07 | 177 | 39 | 6 | 1645_DN | |
| Drug | 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 | 7.59e-07 | 11 | 39 | 3 | ctd:C061137 | |
| Drug | AC1L2E0P | 8.04e-07 | 307 | 39 | 7 | CID000019390 | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.09e-06 | 200 | 39 | 6 | 5853_DN | |
| Drug | dihydroxy-vitamin D3 | 1.31e-06 | 13 | 39 | 3 | ctd:C118756 | |
| Drug | CV-1 | 1.58e-06 | 213 | 39 | 6 | CID000130105 | |
| Drug | Dihydrotestosterone | 2.32e-06 | 360 | 39 | 7 | ctd:D013196 | |
| Drug | ferutinin | 2.56e-06 | 16 | 39 | 3 | CID000354654 | |
| Drug | iclaprim | 3.82e-06 | 62 | 39 | 4 | CID000213043 | |
| Drug | galangin | 5.53e-06 | 68 | 39 | 4 | ctd:C037032 | |
| Drug | hydroxyethylretinamide | 7.35e-06 | 73 | 39 | 4 | CID006437840 | |
| Drug | Aldosterone | 1.01e-05 | 79 | 39 | 4 | ctd:D000450 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.09e-05 | 172 | 39 | 5 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.12e-05 | 173 | 39 | 5 | 5987_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.15e-05 | 174 | 39 | 5 | 909_DN | |
| Drug | glutamin | 1.17e-05 | 461 | 39 | 7 | CID000000738 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.18e-05 | 175 | 39 | 5 | 1014_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.21e-05 | 176 | 39 | 5 | 981_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.25e-05 | 177 | 39 | 5 | 6434_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.28e-05 | 178 | 39 | 5 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.28e-05 | 178 | 39 | 5 | 1672_DN | |
| Drug | androstenol | 1.32e-05 | 27 | 39 | 3 | CID000101989 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.35e-05 | 180 | 39 | 5 | 4821_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.39e-05 | 181 | 39 | 5 | 7005_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.39e-05 | 181 | 39 | 5 | 6951_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.50e-05 | 184 | 39 | 5 | 2321_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.50e-05 | 184 | 39 | 5 | 5671_DN | |
| Drug | 3-hydroxyflavone | 1.65e-05 | 29 | 39 | 3 | ctd:C041477 | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 39 | 5 | 2367_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 39 | 5 | 5061_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 3769_DN | |
| Drug | TCPOBOP | 2.09e-05 | 95 | 39 | 4 | CID000005382 | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 5837_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.19e-05 | 199 | 39 | 5 | 7030_DN | |
| Drug | MF101 extract | 2.85e-05 | 5 | 39 | 2 | ctd:C517398 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 2.85e-05 | 5 | 39 | 2 | ctd:C575894 | |
| Drug | Cyproterone Acetate | 2.93e-05 | 35 | 39 | 3 | ctd:D017373 | |
| Drug | 2',3',4',5'-tetrachloro-4-biphenylol | 4.27e-05 | 6 | 39 | 2 | ctd:C104006 | |
| Drug | androstan-3-ol | 4.27e-05 | 6 | 39 | 2 | ctd:C000658 | |
| Drug | Diethylstilbestrol | NCOA2 NCOA1 NFKBIZ ERBB3 ZFAND5 TOB1 SLC4A4 CREBBP GLI1 EP300 | 5.10e-05 | 1305 | 39 | 10 | ctd:D004054 |
| Drug | bicalutamide | 6.14e-05 | 125 | 39 | 4 | CID000002375 | |
| Drug | AC1ND2OB | 8.57e-05 | 265 | 39 | 5 | CID004568637 | |
| Drug | AC1LA6KT | 9.14e-05 | 51 | 39 | 3 | CID000508110 | |
| Drug | 4,4'-hexafluorisopropylidene diphenol | 1.01e-04 | 142 | 39 | 4 | ctd:C583074 | |
| Drug | 2-acetyltributylcitrate | 1.02e-04 | 9 | 39 | 2 | ctd:C014953 | |
| Drug | tris(chloroethyl)phosphate | 1.15e-04 | 55 | 39 | 3 | ctd:C031324 | |
| Drug | NSC98537 | 1.42e-04 | 473 | 39 | 6 | CID000005410 | |
| Drug | fulvestrant | 1.61e-04 | 484 | 39 | 6 | ctd:C070081 | |
| Drug | AC1NRNSN | 1.72e-04 | 63 | 39 | 3 | CID005244174 | |
| Drug | monomethyl phthalate | 1.82e-04 | 957 | 39 | 8 | ctd:C517284 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.84e-04 | 166 | 39 | 4 | 2268_DN | |
| Drug | Androstenols | 1.87e-04 | 12 | 39 | 2 | ctd:D000737 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.97e-04 | 169 | 39 | 4 | 5231_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.97e-04 | 169 | 39 | 4 | 6064_DN | |
| Drug | In-G | 2.01e-04 | 170 | 39 | 4 | CID000446054 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.01e-04 | 170 | 39 | 4 | 7043_DN | |
| Drug | ethylnylestradiol | 2.10e-04 | 1251 | 39 | 9 | CID000003285 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 172 | 39 | 4 | 5209_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 172 | 39 | 4 | 1637_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 172 | 39 | 4 | 2794_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.15e-04 | 173 | 39 | 4 | 2881_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.15e-04 | 173 | 39 | 4 | 3243_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.20e-04 | 174 | 39 | 4 | 3462_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.20e-04 | 174 | 39 | 4 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.20e-04 | 174 | 39 | 4 | 5065_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.25e-04 | 175 | 39 | 4 | 5935_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.25e-04 | 175 | 39 | 4 | 7236_DN | |
| Drug | 2,6-dihydroxybenzoic acid | 2.25e-04 | 175 | 39 | 4 | CID000009338 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.30e-04 | 176 | 39 | 4 | 3312_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.30e-04 | 176 | 39 | 4 | 7499_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.30e-04 | 176 | 39 | 4 | 1535_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.35e-04 | 177 | 39 | 4 | 7047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.35e-04 | 177 | 39 | 4 | 3227_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.35e-04 | 177 | 39 | 4 | 3177_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.40e-04 | 178 | 39 | 4 | 7245_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.40e-04 | 178 | 39 | 4 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.40e-04 | 178 | 39 | 4 | 4710_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.45e-04 | 179 | 39 | 4 | 6609_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.45e-04 | 179 | 39 | 4 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.45e-04 | 179 | 39 | 4 | 2105_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.45e-04 | 179 | 39 | 4 | 4483_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.50e-04 | 180 | 39 | 4 | 3688_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.50e-04 | 180 | 39 | 4 | 6886_DN | |
| Drug | Fmoc | 2.57e-04 | 14 | 39 | 2 | CID000034367 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.61e-04 | 182 | 39 | 4 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.61e-04 | 182 | 39 | 4 | 1951_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.67e-04 | 183 | 39 | 4 | 7498_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.67e-04 | 183 | 39 | 4 | 4770_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.72e-04 | 184 | 39 | 4 | 6939_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.78e-04 | 185 | 39 | 4 | 1114_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.78e-04 | 185 | 39 | 4 | 5882_DN | |
| Drug | febuxostat | 2.88e-04 | 75 | 39 | 3 | CID000134018 | |
| Drug | 2,3,4,7,8-pentachlorodibenzofuran | 2.88e-04 | 75 | 39 | 3 | ctd:C038890 | |
| Drug | bicalutamide | 2.95e-04 | 188 | 39 | 4 | ctd:C053541 | |
| Disease | Malignant neoplasm of breast | NCOA2 ZCCHC14 NCOA1 NCOA3 NCOA6 ERBB3 ARID1B ARID1A YAP1 GLI1 EP300 | 6.89e-08 | 1074 | 38 | 11 | C0006142 |
| Disease | Breast Carcinoma | 3.51e-07 | 538 | 38 | 8 | C0678222 | |
| Disease | Prostatic Neoplasms | 9.71e-07 | 616 | 38 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.71e-07 | 616 | 38 | 8 | C0376358 | |
| Disease | Bladder Neoplasm | 9.90e-07 | 140 | 38 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.03e-06 | 141 | 38 | 5 | C0005684 | |
| Disease | Menke-Hennekam syndrome | 1.61e-06 | 2 | 38 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.61e-06 | 2 | 38 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.61e-06 | 2 | 38 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.61e-06 | 2 | 38 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.61e-06 | 2 | 38 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.61e-06 | 2 | 38 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.61e-06 | 2 | 38 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 1.61e-06 | 2 | 38 | 2 | C0035934 | |
| Disease | prostate cancer (is_marker_for) | 1.69e-06 | 156 | 38 | 5 | DOID:10283 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.03e-06 | 195 | 38 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.61e-05 | 5 | 38 | 2 | C3281201 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.03e-05 | 41 | 38 | 3 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 2.03e-05 | 41 | 38 | 3 | C0007138 | |
| Disease | Breast adenocarcinoma | 2.03e-05 | 41 | 38 | 3 | C0858252 | |
| Disease | mood instability measurement | 2.22e-05 | 128 | 38 | 4 | EFO_0008475 | |
| Disease | Neuroblastoma | 3.07e-05 | 47 | 38 | 3 | C0027819 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.07e-05 | 139 | 38 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Embryonal Rhabdomyosarcoma | 4.50e-05 | 8 | 38 | 2 | C0206656 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.94e-05 | 55 | 38 | 3 | C0079744 | |
| Disease | Mammary Carcinoma, Human | 5.25e-05 | 525 | 38 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.25e-05 | 525 | 38 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 5.36e-05 | 527 | 38 | 6 | C1458155 | |
| Disease | neuroblastoma (is_implicated_in) | 7.22e-05 | 10 | 38 | 2 | DOID:769 (is_implicated_in) | |
| Disease | breast carcinoma (is_marker_for) | 8.53e-05 | 66 | 38 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Coffin-Siris syndrome | 1.25e-04 | 13 | 38 | 2 | C0265338 | |
| Disease | T-Cell Lymphoma | 1.92e-04 | 16 | 38 | 2 | C0079772 | |
| Disease | neutrophil count, basophil count | 1.95e-04 | 224 | 38 | 4 | EFO_0004833, EFO_0005090 | |
| Disease | basophil percentage of leukocytes | 2.66e-04 | 243 | 38 | 4 | EFO_0007992 | |
| Disease | Adenoid Cystic Carcinoma | 2.92e-04 | 100 | 38 | 3 | C0010606 | |
| Disease | neutrophil count | 3.16e-04 | 1382 | 38 | 8 | EFO_0004833 | |
| Disease | Nasopharyngeal carcinoma | 3.67e-04 | 22 | 38 | 2 | C2931822 | |
| Disease | granulocyte percentage of myeloid white cells | 3.85e-04 | 268 | 38 | 4 | EFO_0007997 | |
| Disease | Squamous cell carcinoma | 5.49e-04 | 124 | 38 | 3 | C0007137 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 5.55e-04 | 27 | 38 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | Sezary Syndrome | 5.55e-04 | 27 | 38 | 2 | C0036920 | |
| Disease | response to vaccine, cytokine measurement | 6.44e-04 | 131 | 38 | 3 | EFO_0004645, EFO_0004873 | |
| Disease | verbal-numerical reasoning measurement | 6.44e-04 | 131 | 38 | 3 | EFO_0008394 | |
| Disease | intestinal cancer (implicated_via_orthology) | 7.82e-04 | 32 | 38 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | colon cancer (is_implicated_in) | 9.90e-04 | 36 | 38 | 2 | DOID:219 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.91e-04 | 152 | 38 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | testosterone measurement | 1.08e-03 | 1275 | 38 | 7 | EFO_0004908 | |
| Disease | colorectal cancer (is_marker_for) | 1.09e-03 | 157 | 38 | 3 | DOID:9256 (is_marker_for) | |
| Disease | HVA measurement, 5-HIAA measurement | 1.16e-03 | 39 | 38 | 2 | EFO_0005131, EFO_0005132 | |
| Disease | Endometrioma | 1.17e-03 | 161 | 38 | 3 | C0269102 | |
| Disease | Endometriosis | 1.17e-03 | 161 | 38 | 3 | C0014175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLLSPSSGYMPMNQG | 1046 | P21860 | |
| LTSPNMGMGTSGPNQ | 131 | Q09472 | |
| SGPNQGPTQSTGMMN | 141 | Q09472 | |
| GRQNMQYPNPGMGSA | 201 | Q09472 | |
| QVSQGMNSFNPMSLG | 716 | Q92793 | |
| QNQFPSSSGAMSVGM | 796 | Q92793 | |
| NINNSMPPGRTGMGT | 1976 | Q92793 | |
| LSQSPMPQERGFMAG | 851 | Q8NFD5 | |
| QMAQYGPQQTGPSMS | 871 | Q8NFD5 | |
| SAGMQNRPFPGNMSS | 971 | Q8NFD5 | |
| NRPFPGNMSSMTPSS | 976 | Q8NFD5 | |
| QGSFPGMNQSGLMAS | 1031 | Q8NFD5 | |
| RNSMTPNAPYQQGMS | 1321 | Q8NFD5 | |
| PNRMMSNTPGNGLAS | 86 | Q9P2D1 | |
| PAGMNGSGAPMNLNN | 256 | Q9NTZ6 | |
| TPNPGYQPSMNTSDM | 1206 | O14497 | |
| SSIMGMQGPNLSNPC | 206 | Q02930 | |
| PGSQNMPQSSLYGMA | 746 | Q92585 | |
| NTSLPFSNMGNPMNT | 396 | Q9BYH8 | |
| TTAQMGQPQAPMGSY | 561 | Q9HCD5 | |
| IGTMSPSLGFPAQMN | 126 | P08151 | |
| GPTPNMQGNMVQFTG | 746 | Q14686 | |
| LENNPMNGNIMGSPF | 131 | Q13495 | |
| SLNRMNGVMFPGNSP | 146 | Q9NY27 | |
| DPTRQQGHPNMGGSM | 186 | Q9BWW4 | |
| SSMQTGMNPSAMQGP | 161 | Q8N5C8 | |
| ATAGQSSPMPQMGSE | 161 | O76081 | |
| AFSPGMGMQPRQTLN | 1031 | Q15788 | |
| GGNPRMMDSQENYGS | 886 | Q9Y6Q9 | |
| PPNAMMSSRMGPSQN | 1331 | Q9Y6Q9 | |
| RMSQNFPNGGAMDTH | 866 | O43147 | |
| QPSMSQAGMRQSGTN | 51 | Q86VE3 | |
| AMQINSYGSGMAPPS | 126 | O94855 | |
| KMNSPSQSSPGMNPG | 466 | Q15596 | |
| SQSSPGMNPGQPTSM | 471 | Q15596 | |
| SPMNIPGSNQSSAMN | 421 | Q9UPV9 | |
| GNSMAMAFQVPPNSP | 131 | Q96AW1 | |
| QQALNGMAPPGDTAM | 6 | P32971 | |
| QQNSGRMSPMGTASG | 41 | O76080 | |
| ANPGGSNSMPSQSRS | 621 | Q5PRF9 | |
| QGPGPNQLNMTNSSM | 136 | Q15532 | |
| SQPPQSSTMGYMGSQ | 686 | O14964 | |
| QQNMMNSASGPLPDG | 221 | P46937 | |
| FNCPPNSTMNRGMDS | 731 | P78562 | |
| MLNSMQDPFGGNPFT | 281 | Q8IYU4 | |
| FPNMQGQGSSTNGMF | 276 | P50616 | |
| GQSTFAVPPMQNFMA | 866 | Q8WYQ9 | |
| RMFTNPDNGSPAMTH | 236 | Q9Y6R1 | |
| PQMQAPSGMNGTSLS | 491 | Q8NDV7 | |
| VQAMNSAGLGQPSMP | 876 | Q5VTT5 |